Robert Marchesani

Robert Marchesani is a declared insider of Isofol Medical AB, with filings sourced from Finansinspektionen. We count 4 filings; the first trade dates from 24 June 2019 and the latest from 26 June 2019.

Purchases make up the whole of the open-market record (4 purchases, €9,896). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Half of the purchases are above €1,880 and half below. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 26 June 2019 with an open-market purchase (€1,419) in Isofol Medical AB. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.